OpenVSafe by OpenVAERS
Search V-safe

F68-17786-22655

3 vaccinations 6 coded responses 32 check-ins 5 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
601 / IL
Registered
2021-04-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
LCN-21234-67569 Child or adolescent in my care · Male · 2022-02-10
2JA-82453-66392 Child or adolescent in my care · Male · 2022-02-10

Timeline

  1. 2021-04-07
    Dose 1 — Moderna
  2. 2021-04-13
    Registered in v-safe
  3. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-14
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-04-21
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  6. 2021-04-29
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  7. 2021-05-05
    Dose 2 — Moderna
  8. 2021-05-05
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-05-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-05-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  12. 2021-05-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  13. 2021-05-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  14. 2021-05-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  15. 2021-05-12
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-05-19
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-05-26
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-06-02
    Survey response — day 28, dose 2
    MedDRA: Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Headache and fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-06-09
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  20. 2021-06-16
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-08-06
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  22. 2021-11-03
    Survey response — 6 months, dose 2
    MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Cough and congestion
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-02-09
    Dose 3 — Pfizer-BioNTech
  24. 2022-02-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activities
    Adult check-in
  25. 2022-02-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  26. 2022-02-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  27. 2022-02-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  28. 2022-02-18
    Health check-in — day 7, dose 3
    Feeling: Good · Headache · Be unable to do your normal daily activities
    Adult check-in
  29. 2022-02-23
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  30. 2022-03-02
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-03-09
    Survey response — day 28, dose 3
    MedDRA: Fatigue, Headache — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Extreme fatigue and bad headaches.
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-03-18
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-03-23
    Survey response — day 42, dose 3
    MedDRA: Dysmenorrhoea, Heavy menstrual bleeding, Menstrual clots — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Very heavy menstruation with severe cramps and large clots.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-05-11
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-08-10
    Survey response — 6 months, dose 3
    MedDRA: Chills, Cough, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Fever, chills, runny nose, cough
    MedDRA releases: 2024-11 · check-in free text available
  36. 2023-02-09
    Survey response — 12 months, dose 3
    MedDRA: Delivery, Gestational hypertension, Hypertension — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Hospitalization
    MedDRA releases: 2024-11
  37. 2023-02-09
    Report sent to call center — 12 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
  38. 2023-02-10

Vaccinations

DoseDateManufacturerCo-administered
12021-04-07Moderna
22021-05-05Moderna
32022-02-09Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 8 — day 28, dose 2

2021-06-02

Symptoms: Headache and fatigue

Release 10 — 6 months, dose 2

2021-11-03

Symptoms: Cough and congestion

Release 11 — day 28, dose 3

2022-03-09

Symptoms: Extreme fatigue and bad headaches.

Release 11 — day 42, dose 3

2022-03-23

Symptoms: Very heavy menstruation with severe cramps and large clots.

Release 12 — 6 months, dose 3

2022-08-10

Symptoms: Fever, chills, runny nose, cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChills · · ✓
SDCough · · ✓
SDDelivery · · ✓
SDDysmenorrhoea · · ✓
SDFatigue ✓ ✓ ✓
SDGestational hypertension · · ✓
SDHeadache ✓ ✓ ✓
SDHeavy menstrual bleeding · · ✓
SDHypertension · · ✓
SDMenstrual clots · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release